Published in Cancer Weekly, October 17th, 2006
As a consultant, Colowick will continue to provide strategic input and work closely with the company in an advisory role in executing the company's ongoing clinical studies. In the interim, the medical aspects of Colowick's responsibilities will be managed by Michael Brawer, who joined Threshold as a member of the management team earlier this year.
Brawer, a consultant to Threshold Pharmaceuticals since 2004,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.